Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine

International Journal of Medical Sciences

Volumn 8, Issue 3, 2011, Pages 239-244

  Smith Norowitz, Tamar A ^a,b   Wong, Darrin ^b   Kusonruksa, Melanie ^b   Norowitz, Kevin B ^a,b   Joks, Rauno ^b   Durkin, Helen G ^b   Bluth, Martin H ^c  

^a SUNY Downstate Medical Center   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ige; Influenza virus; Influenza virus vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LONG TERM EXPOSURE; MALE;

EID: 79955536974     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.239     Document Type: Article

References (34)

1. Bluth MH, Norowitz KB, Chice S, Shah VN, Nowakowski M, Josephson AS, Durkin HG, Smith-Norowitz TA. Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvo-virus B19 infection: relation to Th2 Cytokines. Clin. Immunol 2003; 108:152-158.
2. Secord EA, Kleiner GI, Auci DL, et al. IgE against HIV proteins in clinically healthy childen with HIV disease. J Allergy Clin Immunol 1996; 98: 979-84.
3. Pellegrino MG, Bluth MH, Smith-Norowitz TA, et al. HIV-1 Specific IgE in serum of long term surviving children inhibits HIV-1 production in vitro. AIDS Res. Hum. Retroviruses 2002; 18: 363-72.
4. Lev Tov H, Josekutty J, Kohlhoff S., Norowitz KB, Silverberg JI, Chice S, Nowakowski M, Durkin HG, Bluth MH, Smith-Norowitz TA. IgE anti-varicella virus (VZV) and otherimmune responses before, during, and after shingles. J Allergy Clin Immunol. 2008; 121: S207.
5. Smith-Norowitz TA, J Josekutty, H Lev-Tov, S Kohlhoff, KB Norowitz, JI Silverberg, S Chice, HG Durkin, MH Bluth. IgE anti-Varicella Zoster virus and other immune responses before, during, and after shingles. Ann Clin Lab Sci. 2009; 39 (1): 43-50.
6. Smith-Norowitz TA, Josekutty J, Lev-Tov H, Norowitz KB, Kohlhoff SA, Silverberg JI, Nowakowski M, Durkin HG, Bluth MH. Long term persistence of IgE anti-Varicella Zoster Virus in pediatric and adult serum post chicken pox infection and after vaccination with Varicella Virus vaccine. Int J Biomed Sci. 2009;: 100-105.
7. Bluth MH, Robin J, Ruditsky M, Norowitz KB, Chice S, Pytlak E, Nowakowski M, Durkin HG, Smith-Norowitz TA. IgE an-ti-borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with lyme diseaese. Scan J Immunol 2007; 65: 376-382.
8. Welliver RC, Wong DT, Sun M, Middleton JrE, Vaughan RS, Ogra PL. The development of respiratory syncytial vi-rus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. New England J. of Med 1981; 305: 841-846.
9. Russi JC, Delfraro A, Borthagaray MD, Velazques B, Gar-cia-Barreno B, Hortal, M. Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal se-cretions of children with respiratory syncytial virus infection. J. Clin. Microbiol 1993; 31: 819-823.
10. Welliver RC, Wong DT, Middleton JrE, Sun M, McCarthy N, Ogra PL. Role of parainfluenza virus-specific IgE in pathogen-esis of croup and wheezing subsequent to infection. J. Pediatrics 1982; 101: 889-896.
11. Beaudouin E, Kanny G, Guerin B, Guerin L, Plenat F, Moneret-Vautrin DA. Unusual manifestations of hypersensi-tivity after a tick bite: report of two cases. Ann Allergy Asthma Immunol 1997; 79: 43-46.
12. Alexeyev OA, Ahlm C, Billheden J, Settergren B, Wadell G, Juto P. Elevated levels of total and Puumala virus-specific immuno-globulin E in the Scandinavian type of hemorrhagic fever with renal syndrome. Clin. Diag. Lab. Immunol 1994; 1: 269-272.
13. Kennedy CR, Bird D, Chrzanowska K, Stephens S, Webster AD. The pathogenesis of virus-associated encephalopathies: a pro-spective study of immunological mechanisms. Clin. Immunol. Immunopathol 1987; 42: 218-228.
14. Odeon AC, Gershwin LJ, Osburn BI. IgE responses to blue-tongue virus (BTV) serotype 11 after immunization with inac-tivated BTV and challenge infection. Comp Immunol Imcrobiol Infect Dis. 1999; 22: 145-163.
15. Grunewald SM, Hahn C, Wohlleben G, Teufel M, Major T, Moll H, Brocker E-B, Erb KJ. Infection with Influenza A virus leads to flu antigen-induced cutaneous anaphylaxis in mice. J Invest Dermatol 2002; 118: 645-651.
16. Davidsson A, Eriksson JC, Rudblad S, Brokstad KA. Influenza specific serum IgE is present in non-allergic subjects. Scan J Immunol 2005; 62(6): 560-561.
17. Dobber R, Tielemans M, Nagelkerken L. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice. Cell Immunol 1995; 160: 185-192.
18. Brokstad KA, Eriksson JC, Cox RJ, Tynning T, Olofsson J, Jonsson R, Davidsson A. Parenteral vaccination against influ-enza does not induce a local antigen-specific immune response in the nasal mucosa. J Infect Dis 2002; 185(7): 878-884.
19. Brokstad KA, Cox RJ, Oxford JS, Haaheim LR. IgA, IgA sub-classes, and secretory component levels in oral fluid collected from subjects after parenteral influenza vaccination. J Infect Dis 1995; 171: 1072-1074.
20. Wright PF, Webster RG. Orthomyxoviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, eds. Fields Virology, 4th edn. Philadelphia, PA: Lip-pincott Williams & Wilkins, 2001: 1533-79.
21. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scan J Im-munol 2004; 59: 1-15.
22. Gonchoroff NJ, Kendal AP, Phillips DJ, Reimer CB. Immuno-globulin M and G antibody response to type- and sub-type-specific antigens after primary and secondary exposures of mice to Influenza A viruses. Infect and Immunity 1983;: 510-517.
23. Lui K-J, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Pub-lic Health 1987; 77: 712-716.
24. Glezan WP, Taber LH, Frank AL, Gruber WC, Piedra PA. In-fluenza virus infection in infants. Pediatr Infect Dis J 1997; 16: 1065-1068.
25. [Internet] CDC. 2010-11 Influenza Prevention & Control Rec-ommendations: Primary Changes and Updates in the 2010 ACIP Recommendations. http://www.cdc.gov/flu/professionals/acip/primarychanges.htm
26. Clements ML, O'Donnell S, Levine MM, Chanock RM, Murphy BR. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local anti-body in resistance to infection with vaccine virus. Infect Immun 1983; 40: 1044-1051.
27. Clements ML, Betts RF, Tierney EI, Murphy BR. Serum and nasal wash antibodies associated with resistance to experi-mental challenge with influenza A wild-type virus. J Clin Mi-crobiol 1986; 24: 157-160.
28. Clements ML, Murphy BR. Development and persistence of local and systemic antibody responses in adults given live at-tenuated or inactivated influenza A virus vaccine. J Clin Mi-crobiol 1986; 23: 66-72.
29. Yewdell JW, Hackett CJ. The specificity and function of T lymphocytes and antibody dependent complement-mediated cytotoxicity induced by administration of influenza vaccine. Infect Immun 1980; 30: 362-369.
30. Murphy BR, Clements ML. The systemic and mucosal immune response of humans to Influenza A virus. In: Mestecky J, McGhee JR, eds. Current Topics in Microbiology and Immu-nology. New York, NY: Springer Verlag, 1989, 107-116.
31. Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994; 12: 993-999.
32. Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001; 14: 430-445.
33. Fu S, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH. IgE antibodies from pancreatic cancer patients mediate antibody-dependent cell meditate cytotoxicity (ADCC) against pancreatic cancer cells. Clin and Exp Immunol 2008;153:401-409
34. TP Monath, R Nichols, WT Archambault, L Moore, R Marche-sani, J Tian, RE Shope, N Thomas, R Schrader, D Furby, and P Bedford. Comparative safety and immunogenicity of two yel-low fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. Am. J. Trop. Med. Hyg. 2002;66:533-541